Figure 3: Relative number of laboratories which perform NATs for the listed pathogens (blue bars). Percentage of manufacturers providing corresponding kits (red bars). The data are taken from Tables 3 and 4. MRSA: methicillin-resistant Staphylococcus aureus; SARS-CoV: severe acute respiratory syndrome associated coronavirus; CMV: human cytomegalovirus; HIV: human immunodeficiency virus; EBV: Epstein-Barr virus; HBV/HCV: hepatitis B and C viruses.